Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains

Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains

Non-degradative ubiquitin chains and phosphorylation events govern signaling responses by innate immune receptors. The deubiquitinase CYLD in complex with SPATA2 is recruited to receptor signaling complexes by the ubiquitin ligase LUBAC and regulates Met1- and Lys63-linked polyubiquitin and receptor...

Bibliografski detalji
Glavni autori:	Elliott, PR, Leske, D, Wagstaff, J, Schlicher, L, Berridge, G, Maslen, S, Timmermann, F, Ma, B, Fischer, R, Freund, SMV, Komander, D, Gyrd-Hansen, M
Format:	Journal article
Jezik:	English
Izdano:	Cell Press 2021

Slični predmeti

SPATA2 links CYLD to LUBAC, activates CYLD and controls LUBAC signaling
od: Elliott, P, i dr.
Izdano: (2016)

CYLD limits Lys63- and Met1-linked ubiquitin at receptor complexes to regulate innate immune signaling
od: Gyrd-Hansen, M, i dr.
Izdano: (2016)

Regulation of the deubiquitinase CYLD in innate immune signalling
od: Leske, D
Izdano: (2018)

Molecular basis and regulation of OTULIN-LUBAC interaction
od: Elliott, PR, i dr.
Izdano: (2014)

All roads lead to ubiquitin
od: Gyrd-Hansen, M
Izdano: (2017)

The role of CYLD in macrophages
od: Zucca, M
Izdano: (2018)

The Met1-linked ubiquitin machinery in inflammation and infection
od: Fiil, BK, i dr.
Izdano: (2021)

Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
od: Tauriello, D, i dr.
Izdano: (2010)

Met1-linked ubiquitination in immune signalling
od: Fiil, B, i dr.
Izdano: (2014)

Met1-linked ubiquitination in immune signalling.
od: Fiil, B, i dr.
Izdano: (2014)

A novel large deletion of the CYLD gene causes CYLD cutaneous syndrome in a Chinese family
od: Ruizheng Zhu, i dr.
Izdano: (2020-10-01)

OTULIN restricts Met1-linked ubiquitination to control innate immune signaling.
od: Fiil, B, i dr.
Izdano: (2013)

Analysis of the Ubiquitination and Phosphorylation of Vangl Proteins
od: Di Feng, i dr.
Izdano: (2022-10-01)

The Met1-linked ubiquitin machinery: Emerging themes of (de)regulation
od: Hrdinka, M, i dr.
Izdano: (2017)

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
od: K. C. Masoumi, i dr.
Izdano: (2011-01-01)

Molecular basis and regulation of OTULIN-LUBAC interaction
od: Elliott, P, i dr.
Izdano: (2014)

Molecular basis and regulation of OTULIN-LUBAC interaction.
od: Elliott, P, i dr.
Izdano: (2014)

Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium
od: Jae Yong Byun, i dr.
Izdano: (2010-01-01)

Secondary interactions in ubiquitin-binding domains achieve linkage or substrate specificity
od: Martin A. Michel, i dr.
Izdano: (2024-08-01)

Cooperative Substructure and Energetics of Allosteric Regulation of the Catalytic Core of the E3 Ubiquitin Ligase Parkin by Phosphorylated Ubiquitin
od: Xiang Ye, i dr.
Izdano: (2024-10-01)

Lysosomal interplay between ubiquitination and phosphorylation regulates chaperone-mediated autophagy
od: Rakshit, Moumita
Izdano: (2017)

Revealing the Mechanism of Protein Degradation in Postmortem Meat: The Role of Phosphorylation and Ubiquitination
od: Xinran Zhao, i dr.
Izdano: (2025-01-01)

DCM troponin C mutant Gly159Asp blunts the response to troponin phosphorylation.
od: Preston, L, i dr.
Izdano: (2007)

SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation
od: Fabio Bordin, i dr.
Izdano: (2024-12-01)

Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling
od: Nikhar, S, i dr.
Izdano: (2021)

Novel CYLD pathogenic variant associated with multiple cylindromas of the scalp—A case report
od: Inês P. Amaral, i dr.
Izdano: (2024-10-01)

CYLD alleviates NLRP3 inflammasome-mediated pyroptosis in osteoporosis by deubiquitinating WNK1
od: Guiyong Jiang, i dr.
Izdano: (2024-04-01)

P1225: CYLD, A NOVEL REGULATOR OF SPLENIC MARGINAL ZONE LYMPHOMA PATHOGENESIS
od: Athanasios Pseftogkas, i dr.
Izdano: (2023-08-01)

CYLD regulates cell ferroptosis through Hippo/YAP signaling in prostate cancer progression
od: Yanan Gu, i dr.
Izdano: (2024-01-01)

Phosphorylation of tau at a single residue inhibits binding to the E3 ubiquitin ligase, CHIP
od: Cory M. Nadel, i dr.
Izdano: (2024-09-01)

ATR‐dependent ubiquitin‐specific protease 20 phosphorylation confers oxaliplatin and ferroptosis resistance
od: Jianing Tang, i dr.
Izdano: (2023-12-01)

Interaction mapping of endoplasmic reticulum ubiquitin ligases identifies modulators of innate immune signalling
od: Fenech, EJ, i dr.
Izdano: (2020)

Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase
od: Klaessens, S, i dr.
Izdano: (2021)

VPO1 Promotes Programmed Necrosis of Cardiomyocytes in Rats with Chronic Heart Failure by Upregulating CYLD
od: Yinzhuang Zhang, i dr.
Izdano: (2024-12-01)

CYLD Maintains Retinal Homeostasis by Deubiquitinating ENKD1 and Promoting the Phagocytosis of Photoreceptor Outer Segments
od: Song Yang, i dr.
Izdano: (2024-12-01)

TRIM47 drives gastric cancer cell proliferation and invasion by regulating CYLD protein stability
od: Jianguo Wang, i dr.
Izdano: (2024-11-01)

The Proteasome and Cul3-Dependent Protein Ubiquitination Is Required for Gli Protein-Mediated Activation of Gene Expression in the Hedgehog Pathway
od: Tomasz Uśpieński, i dr.
Izdano: (2024-09-01)

Functional analysis of the C. elegans cyld-1 gene reveals extensive similarity with its human homolog
od: Hadweh, P, i dr.
Izdano: (2018)

CYLD expression in dendritic cells involved in the immunoregulation of pulmonary adenocarcinoma via NF-κB pathway
od: Qinghua Yu, i dr.
Izdano: (2020-01-01)

Structural basis for antagonism of the ubiquitin ligase BIRC6 by SMAC
od: Dietz, L, i dr.
Izdano: (2022)